[
  {
    "ts": "2025-04-18T13:15:20+00:00",
    "headline": "Unlocking Q1 Potential of Edwards Lifesciences (EW): Exploring Wall Street Estimates for Key Metrics",
    "summary": "Evaluate the expected performance of Edwards Lifesciences (EW) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",
    "url": "https://finance.yahoo.com/news/unlocking-q1-potential-edwards-lifesciences-131520436.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "a21e106a-2e8a-3701-a018-096b3a2aa117",
      "content": {
        "id": "a21e106a-2e8a-3701-a018-096b3a2aa117",
        "contentType": "STORY",
        "title": "Unlocking Q1 Potential of Edwards Lifesciences (EW): Exploring Wall Street Estimates for Key Metrics",
        "description": "",
        "summary": "Evaluate the expected performance of Edwards Lifesciences (EW) for the quarter ended March 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.",
        "pubDate": "2025-04-18T13:15:20Z",
        "displayTime": "2025-04-18T13:15:20Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/4f1a8d86cead9f96536efb147945dcc9",
          "originalWidth": 900,
          "originalHeight": 565,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/YtAJ1dNJrNLDESvqOxl.SQ--~B/aD01NjU7dz05MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4f1a8d86cead9f96536efb147945dcc9.cf.webp",
              "width": 900,
              "height": 565,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/G.P5BxCVxDtGSv3VMOFVgA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4f1a8d86cead9f96536efb147945dcc9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/unlocking-q1-potential-edwards-lifesciences-131520436.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/unlocking-q1-potential-edwards-lifesciences-131520436.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-04-18T12:00:00+00:00",
    "headline": "Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue",
    "summary": "CAIRO, April 18, 2025--Edwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESILIA tissue technology have significantly improved long-term outcomes compared to those receiving non-RESILIA tissue bioprosthetic valves.",
    "url": "https://finance.yahoo.com/news/eight-data-confirm-long-term-120000460.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "1da7f773-37bf-38ef-93b2-e734f3d77b00",
      "content": {
        "id": "1da7f773-37bf-38ef-93b2-e734f3d77b00",
        "contentType": "STORY",
        "title": "Eight-Year Data Confirm Long-Term Durability of Edwards’ RESILIA Tissue",
        "description": "",
        "summary": "CAIRO, April 18, 2025--Edwards Lifesciences (NYSE: EW) today announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary RESILIA tissue technology have significantly improved long-term outcomes compared to those receiving non-RESILIA tissue bioprosthetic valves.",
        "pubDate": "2025-04-18T12:00:00Z",
        "displayTime": "2025-04-18T12:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/6061bb9794809f85875c6749a0a48c57",
          "originalWidth": 1024,
          "originalHeight": 512,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/A6wI4i26b7tPRMPeLlOxRg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/6061bb9794809f85875c6749a0a48c57.cf.webp",
              "width": 1024,
              "height": 512,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/XTkTkTj7YpLQIUIa9Ga4hw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/6061bb9794809f85875c6749a0a48c57.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/eight-data-confirm-long-term-120000460.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/eight-data-confirm-long-term-120000460.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "EW"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]